Parexel wird von EQT Private Equity und Goldman Sachs Asset Management übernommen
July 06, 2021 14:52 ET
|
Parexel International LLC
BOSTON und DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) -- Parexel, ein weltweit führendes Auftragsforschungsinstitut (CRO), das sich auf die Entwicklung und Bereitstellung innovativer neuer...
Parexel Adquirida por EQT Private Equity e Goldman Sachs Asset Management
July 06, 2021 14:52 ET
|
Parexel International LLC
BOSTON e DURHAM, N.C., July 06, 2021 (GLOBE NEWSWIRE) -- A Parexel, principal organização global de pesquisa clínica (clinical research organization - CRO) focada no desenvolvimento e entrega de...
Parexel akan Diperoleh oleh EQT Private Equity dan Goldman Sachs Asset Management
July 06, 2021 14:52 ET
|
Parexel International LLC
BOSTON dan DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, sebuah organisasi penyelidikan klinikal global (CRO) terkemuka yang berfokus pada pembangunan dan penyampaian terapi baharu yang...
Parexel, EQT Private Equity와Goldman Sachs Asset Management가 인수
July 06, 2021 14:52 ET
|
Parexel International LLC
보스턴, 노스캐롤라이나주 더럼, July 07, 2021 (GLOBE NEWSWIRE) -- 환자 건강 증진을 위한 혁신적인 신약 개발 및 공급에 중점을 두고 있는 글로벌 CRO(임상시험수탁기관)인 Parexel은 EQT IX 펀드(“EQT Private Equity”)와 Goldman Sachs Asset Management...
Parexel s'apprête à être acquise par EQT Private Equity et Goldman Sachs Asset Management
July 06, 2021 14:52 ET
|
Parexel International LLC
BOSTON et DURHAM, Caroline du Nord, 06 juill. 2021 (GLOBE NEWSWIRE) -- Parexel, une organisation de recherche clinique (CRO) de premier plan à l'échelle mondiale axée sur le développement et la...
Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management
July 02, 2021 10:33 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 02, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Introduces Discussions on Diversity Research to Promote Diversity in Clinical Trials
May 20, 2021 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth...
Parexel Recognized as Most Favored Provider in ISR CRO Phase I Quality Benchmarking Report
May 13, 2021 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Achieves Top Rankings in Industry Across Multiple Attributes in ISR CRO Phase II-III Benchmarking Report
May 04, 2021 09:00 ET
|
Parexel International LLC
BOSTON and Durham, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Designs and Accelerate Patient Matching in Oncology Clinical Trials
February 04, 2021 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C. and FT. MYERS, Fla., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve...